Author:
Brandis Mathias,Kontny Udo
Reference25 articles.
1. Andreoli SP (1998) Renal manifestations of systemic diseases. Semin Nephrol 18:270–279
2. Andreoli SP, Trachtman H, Acheson DWK et al (2002) Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 17:293–298
3. Coppo P, Veyradier A, Durey MA et al (2002) Pathophysiology of thrombotic microangiopathies: current understanding. Ann Med Interne 153:153–166
4. Elliott EJ, Robins-Browne RM, O’Loughlin EV et al (2001) Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 85:125–131
5. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339(22):1578–84.